Dirui Industrial Co.,Ltd. (300396.SZ)
CNY 13.59
(0.07%)
CNY 13.59
(0.07%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.32 Billion CNY | 13.52% |
| 2022 | 2.92 Billion CNY | 23.14% |
| 2021 | 2.37 Billion CNY | 17.4% |
| 2020 | 2.02 Billion CNY | -1.88% |
| 2019 | 2.06 Billion CNY | 3.69% |
| 2018 | 1.98 Billion CNY | 7.45% |
| 2017 | 1.85 Billion CNY | -0.4% |
| 2016 | 1.85 Billion CNY | 5.17% |
| 2015 | 1.76 Billion CNY | 68.8% |
| 2014 | 1.04 Billion CNY | 91.71% |
| 2013 | 546.01 Million CNY | 10.79% |
| 2012 | 492.82 Million CNY | 27.72% |
| 2011 | 385.85 Million CNY | 66.05% |
| 2010 | 232.37 Million CNY | 36.63% |
| 2009 | 170.07 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 3.25 Billion CNY | -2.11% |
| 2024 Q3 | 3.07 Billion CNY | 0.87% |
| 2024 Q2 | 3.04 Billion CNY | -6.34% |
| 2023 Q4 | 3.32 Billion CNY | 8.31% |
| 2023 Q3 | 3.06 Billion CNY | 3.77% |
| 2023 FY | 3.32 Billion CNY | 13.52% |
| 2023 Q1 | 2.99 Billion CNY | 2.41% |
| 2023 Q2 | 2.95 Billion CNY | -1.38% |
| 2022 FY | 2.92 Billion CNY | 23.14% |
| 2022 Q1 | 2.35 Billion CNY | -0.67% |
| 2022 Q4 | 2.92 Billion CNY | 6.35% |
| 2022 Q3 | 2.75 Billion CNY | 8.99% |
| 2022 Q2 | 2.52 Billion CNY | 6.95% |
| 2021 FY | 2.37 Billion CNY | 17.4% |
| 2021 Q1 | 2.05 Billion CNY | 1.74% |
| 2021 Q2 | 2.06 Billion CNY | 0.16% |
| 2021 Q3 | 2.13 Billion CNY | 3.45% |
| 2021 Q4 | 2.37 Billion CNY | 11.36% |
| 2020 Q2 | 2.14 Billion CNY | 0.92% |
| 2020 Q3 | 2.04 Billion CNY | -4.94% |
| 2020 FY | 2.02 Billion CNY | -1.88% |
| 2020 Q1 | 2.12 Billion CNY | 3.15% |
| 2020 Q4 | 2.02 Billion CNY | -0.85% |
| 2019 FY | 2.06 Billion CNY | 3.69% |
| 2019 Q4 | 2.06 Billion CNY | 0.78% |
| 2019 Q3 | 2.04 Billion CNY | 4.67% |
| 2019 Q2 | 1.95 Billion CNY | -0.27% |
| 2019 Q1 | 1.96 Billion CNY | -1.44% |
| 2018 Q1 | 1.83 Billion CNY | -0.74% |
| 2018 FY | 1.98 Billion CNY | 7.45% |
| 2018 Q4 | 1.98 Billion CNY | 0.02% |
| 2018 Q3 | 1.98 Billion CNY | 5.58% |
| 2018 Q2 | 1.88 Billion CNY | 2.51% |
| 2017 Q3 | 1.84 Billion CNY | 0.69% |
| 2017 Q4 | 1.85 Billion CNY | 0.33% |
| 2017 FY | 1.85 Billion CNY | -0.4% |
| 2017 Q1 | 1.76 Billion CNY | -5.29% |
| 2017 Q2 | 1.83 Billion CNY | 4.1% |
| 2016 Q1 | 1.81 Billion CNY | 2.53% |
| 2016 FY | 1.85 Billion CNY | 5.17% |
| 2016 Q4 | 1.85 Billion CNY | 0.32% |
| 2016 Q3 | 1.85 Billion CNY | 1.21% |
| 2016 Q2 | 1.83 Billion CNY | 1.02% |
| 2015 Q4 | 1.76 Billion CNY | 2.29% |
| 2015 Q2 | 1.06 Billion CNY | 1.53% |
| 2015 Q1 | 1.04 Billion CNY | 0.23% |
| 2015 FY | 1.76 Billion CNY | 68.8% |
| 2015 Q3 | 1.72 Billion CNY | 62.17% |
| 2014 Q2 | 569.13 Million CNY | 0.0% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 FY | 1.04 Billion CNY | 91.71% |
| 2014 Q4 | 1.04 Billion CNY | 3.88% |
| 2014 Q3 | 1 Billion CNY | 77.05% |
| 2013 FY | 546.01 Million CNY | 10.79% |
| 2013 Q4 | 546.01 Million CNY | 0.0% |
| 2012 FY | 492.82 Million CNY | 27.72% |
| 2011 FY | 385.85 Million CNY | 66.05% |
| 2010 FY | 232.37 Million CNY | 36.63% |
| 2009 FY | 170.07 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Dian Diagnostics Group Co.,Ltd. | 17.93 Billion CNY | 81.489% |
| Hangzhou Tigermed Consulting Co., Ltd. | 29.69 Billion CNY | 88.818% |
| Beijing Strong Biotechnologies, Inc. | 5.17 Billion CNY | 35.84% |
| Medicalsystem Biotechnology Co., Ltd. | 3.48 Billion CNY | 4.827% |
| Maccura Biotechnology Co.Ltd | 8.11 Billion CNY | 59.1% |
| Guangzhou Wondfo Biotech Co.,Ltd | 5.77 Billion CNY | 42.465% |
| Guangdong Hybribio Biotech Co.,Ltd. | 5.72 Billion CNY | 42.003% |
| BGI Genomics Co., Ltd. | 13.61 Billion CNY | 75.606% |
| Amoy Diagnostics Co., Ltd. | 1.93 Billion CNY | -71.626% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 2.98 Billion CNY | -11.179% |